Reply to Kircher et al

Affiliations

¹ Department of Pathology and Laboratory Medicine, David Geffen School of Medicine.
² Clinical Microbiology Laboratory, University of California, Los Angeles Medical Center.

Comment

Romney M Humphries et al. Clin Infect Dis. 2016.

. 2016 Dec 1;63(11):1532-1533.

doi: 10.1093/cid/ciw604. Epub 2016 Aug 31.

¹ Department of Pathology and Laboratory Medicine, David Geffen School of Medicine.
² Clinical Microbiology Laboratory, University of California, Los Angeles Medical Center.

No abstract available

Comment on

Emerging Resistance, New Antimicrobial Agents … but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape.
Humphries RM, Hindler JA. Humphries RM, et al. Clin Infect Dis. 2016 Jul 1;63(1):83-8. doi: 10.1093/cid/ciw201. Epub 2016 Mar 29. Clin Infect Dis. 2016. PMID: 27025822
The Susceptibility Testing Manufacturers Association Presents an Opinion for the Delay of Current Susceptibility Tests.
Kircher SM, Cullen SK, Killian S, Zimmer BL, Brasso BB; Susceptibility Testing Manufacturers Association (STMA). Kircher SM, et al. Clin Infect Dis. 2016 Dec 1;63(11):1531-1532. doi: 10.1093/cid/ciw602. Epub 2016 Aug 31. Clin Infect Dis. 2016. PMID: 27581763 No abstract available.